Christie Teigland, Ph.D
Christie Teigland, Ph.D
Director/Dr
Inovalon Inc
Bowie,
MD
USA
cteigland1@inovalon.com
Board 7 Factors Explaining the Disparity in Breast Cancer Screening Rates between Dual Eligible and Non-Dual Eligible Medicare Advantage Members